For the quarter ending 2025-09-30, AUPH made $73,468K in revenue. $31,707K in net income. Net profit margin of 43.16%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenue | 73,468 | 70,008 | 62,465 | 55,085 |
| Cost of revenue | 8,177 | 7,115 | 8,574 | 6,652 |
| Selling, general and administrative | 26,182 | 26,018 | 20,339 | 46,036 |
| Research and development | 8,435 | 7,432 | 5,743 | 6,829 |
| Restructuring | 0 | 114 | 1,533 | 7,345 |
| Other expense, net | -929 | -9,246 | -4,429 | 4,316 |
| Total operating expenses | 43,723 | 49,925 | 40,618 | 62,546 |
| Income (loss) from operations | 29,745 | 20,083 | 21,847 | -7,461 |
| Interest income | 3,316 | 3,190 | 3,569 | 4,234 |
| Interest expense | 1,099 | 1,117 | 1,067 | 1,209 |
| Net income before income taxes | 31,962 | 22,156 | 24,349 | -4,418 |
| Income tax expense | 411 | 643 | 1,005 | 242 |
| Net income | 31,551 | 21,513 | 23,344 | -4,660 |
| Unrealized gain (loss) on available-for-sale securities | 156 | -80 | -178 | -193 |
| Comprehensive income | 31,707 | 21,433 | 23,166 | -4,853 |
| Basic (in shares) | 131,808,000 | 134,873,000 | 138,917,000 | -71,660,500 |
| Basic (in usd per share) | 0.24 | 0.16 | 0.17 | -0.035 |
| Diluted (in shares) | 136,008,000 | 137,526,000 | 143,199,000 | -71,783,500 |
| Diluted (in usd per share) | 0.23 | 0.16 | 0.16 | -0.035 |
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)